Q32 Bio (QTTB) Amortizatization of Intangibles (2018 - 2026)
Q32 Bio's quarterly Amortizatization of Intangibles came in at $163000.0 in Q1 2026, up 7.95% year-on-year from $151000.0 in Q1 2025, and down 73.79% quarter-over-quarter from $622000.0 in Q4 2025.
Q32 Bio has reported Amortizatization of Intangibles for 9 years, with the latest figure at $163000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 7.95% year-over-year to $163000.0; the trailing twelve-month figure through Mar 2026 stood at $634000.0 (up 174.46% YoY), and the FY2025 full-year result was $622000.0, up 181.45% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $163000.0, down from $622000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.1 million in Q4 2022, with the low at -$306000.0 in Q3 2025.
- Average Amortizatization of Intangibles over 5 years is $205705.9, with a median of $141000.0 recorded in 2024.
- Year-over-year, Amortizatization of Intangibles surged 450.0% in 2023 and sank 251.8% in 2024.
- Tracing QTTB's Amortizatization of Intangibles over 5 years: stood at $1.1 million in 2022, then slumped by 87.07% to $139000.0 in 2023, then slumped by 251.8% to -$211000.0 in 2024, then surged by 394.79% to $622000.0 in 2025, then sank by 73.79% to $163000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $163000.0 (Q1 2026), $622000.0 (Q4 2025), and -$306000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 163,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163,000.00 |
| Mar 31, 2026 | 163,000.00 |
| Dec 31, 2025 | 622,000.00 |
| Dec 31, 2025 | 622,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Jun 30, 2025 | 155,000.00 |
| Jun 30, 2025 | 155,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Dec 31, 2024 | -211,000.00 |
| Dec 31, 2024 | -211,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 139,000.00 |
| Dec 31, 2023 | 139,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | -133,000.00 |
| Jun 30, 2023 | -133,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Dec 31, 2022 | 1.08 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 781,000.00 |
| Sep 30, 2022 | 781,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Mar 31, 2022 | -38,000.00 |
| Mar 31, 2022 | -38,000.00 |
| Dec 31, 2021 | 1.56 Mn |
| Dec 31, 2021 | 1.56 Mn |
| Sep 30, 2021 | -250,000.00 |
| Sep 30, 2021 | -250,000.00 |
| Jun 30, 2021 | -252,000.00 |
| Jun 30, 2021 | -252,000.00 |
| Mar 31, 2021 | -162,000.00 |
| Mar 31, 2021 | -162,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 18,000.00 |
| Jun 30, 2020 | 18,000.00 |
| Mar 31, 2020 | 175,000.00 |
| Mar 31, 2020 | 175,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Sep 30, 2019 | 401,000.00 |
| Sep 30, 2019 | 401,000.00 |
| Jun 30, 2019 | 539,000.00 |
| Jun 30, 2019 | 539,000.00 |
| Mar 31, 2019 | 661,000.00 |
| Mar 31, 2019 | 661,000.00 |
| Dec 31, 2018 | 1.20 Mn |
| Dec 31, 2018 | 1.20 Mn |
| Sep 30, 2018 | 500,000.00 |
| Sep 30, 2018 | 500,000.00 |
| Jun 30, 2018 | -234,000.00 |
| Jun 30, 2018 | -234,000.00 |
| Mar 31, 2018 | 123,000.00 |
| Mar 31, 2018 | 123,000.00 |